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The reaction of diosgenin (1) with hydrogen peroxide/formic acid was investigated. As a result of this work, 5a-(25R)-spirostane-3/3,5,0/?-triol (2) was prepared in 79% yield and 5a-pregnarie-3/j,5,6/j,16/?,20a-pentol (3) in 80% yield. The pentol (3) was oxidised to 5a-pregnane-3//,5,10ß,20a-tetrol-0-one (5) without forming its 16^,20a-isopropylidenedioxy derivative (4) . Reaction of product 5 with CH^Mgl to give 6-methylpregnane derivative was unsuccessful. Therefore, product 7 was oxidatively degraded by H2O2/HCOOH to the 10-keto pregnane derivative (13) and its structure was proved through its transformation to 0/7-methylpregn-4-ene-0a,20a-diol-3,16-dione (15) .
The importance of the steroid sapogenin, diosgenin as a main precursor in the steroid hormone industry is well known. Diosgenin is converted by Marker degradation [1] to all types of adrenocortical and sex hormones through its transformation to the intermediate compound. pregna-5,16-diene-3/3-ol-20-one. It is reported [2] that the introduction of a methyl group at position six in pregnane compounds increases their progestational activity, this stimulated us to seek a feasible and superior method for the preparation of 6-keto diosgenin derivatives which could be converted to the intermediate 6-methyl pregnane compounds. This work deals with the results obtained on oxidation and sidechain degradation of diosgenin with performic acid, in addition to some other reactions.
In 1954 Romo and his collaborators reported [3] that treatment of diosgenin in tetrahydrofuran with performic acid yielded 5a-spirostan-3/?.5,6/?-triol (2) in 79% yield. When we repeated this method exactly in the same manner [3] on diosgenin, an additional product, C21 H36 O5 was obtained in 20% yield and identified as 5a-pregnane-3ß,5,6/?,16/?,20a-pentol.POL (3) beside the expected triol (2) . By studying the difference in ratio of formic acid and hydrogen peroxide to disogenin and varying the time of reaction, we found that for 0.012 mole diosgenin dissolved in tetrahydrofuran when treated with formic acid/hvdrogen peroxide (1.07/0.09 * Reprint requests to Dr. A. M. Dawidar. 0340-5087/82/0700-0892/5 01.00/0 mole) and shaked for 6 h at room temperature resulted in the formation of the triol (2) only in 98% yield, but when the quantity of formic acid/hydrogen peroxide was double (2.14/0.18 mole) and increasing the time of reaction to 48 h resulted in the formation of pentol (3) in 97% yield. This result concerning the selective oxidation of diosgenin to give either the triol (2) or the pentol POL (3) is feasible and superior to the previous reported methods for their preparation [3] [4] [5] . The compound POL was first prepared by Miki et al. [4] from diosgenin in 70% yield using performic acid and known to exhibit pharmacological activities since it blocks the electrolyte activity of aldosterone [4] , Selective oxidation of the secondary hydroxyl group (/?-axial) at C-6 in POL (3) to give the corresponding 6-keto product was carried out by Miki et al. [4] by protecting the two hydroxyl groups at C-20 and C-16 via the formation of the 16/?,20a-isopropylidenedioxy of POL (4), followed by its oxidation with N-bromosuccinimide in aqueous methenol/ether mixture to yield the 3/3,5-dihydroxy-16/?,20a-isopropylidenedioxy-5a-pregnan-6-one which on treatment with aqueous acetic acid gave 6-keto pentol (5). We found that this last 6-keto product could be formed directly in one step (70% yield) by allowing POL to react with N-bromosuccinimide in 1:2 molar ratio, in a mixture of dioxane/water (30:70).
Our attempt to introduce a methyl group at position six of the 6-keto product (5), its unreported triacetate C27H40O8 (6) or its isopropylidenedioxy derivative via the reaction with methyl magnesium iodide was unsuccessful. Therefore, 5a,(25R)-spiro-stane-3/?,5-diol-6-one (7) was allowed to react with methyl magnesium iodide to yield the known compound 6/5-methyl-5a-(25R)-spirostane-3/?,5,6a-triol (8), cf. Scheme, reported previously by Petrow et al. [5] through the action of perbenzoic acid on diosgenin acetate to give 5a,6a-epoxide followed by treatment with periodic acid to form 5a,6/3-diol-3-acetate. This product was transformed to 6-keto with Sarett oxidation and finally with methyl magnesium iodide then dilute sulphoric acid to yield the desired product (8) .
Oxidation of 8 with Jone's reagent yielded the keto-spirostane compound (9) which on treatment with methanolic potassium hydroxide solution resulted in the selective elemination of the tertairy hydroxylic group at C-5 and formation of the a,ß-unsaturated ketone (10) .
Compound 8 was acetylated to give the mono acetate derivative (11) which on treatment with thionyl chloride in pyridine (Darzen's method) eliminated both the tertairy hydroxyl groups at C-5 and C-6 and formed the diene (12).
Degradation of the spirostane product (8) with performic acid resulted in the formation of a pregnane compound (13), C22H36O5, m.p. 272-275 °C, M+, mje 380. Its IR spectrum showed a strong band at 1750 cm -1 with no indication of the four absorption bands characteristic of the spiroketal sidechain [6] . To be certain that the band at 1750 cm -1 is not due to the H-COO -as a result of the formation of formate ester, the degradative product was refluxed with alcholic potassium hydroxide for six hrs where the starting material was recovered unchanged, based on this fact it was drawn that this IR band at 1750 cm -1 is mostly due to the presence of a ketonic group at C-16. This product showed no absorption in the UV region indicating the absence of any chromophore.
In the product isolated from this degradation process (13), there are three possibilities for the location of the carbonyl group which might be at C-3 or C-16 or C-20. Position three is excluded because refluxing this compound with alcoholic potassium hydroxide did not yield the 4-ene-3-one due to the facile elimination of the 5a-OH group in the presence of the 3-keto group (no absorption in the UV region). The presence of the keto group at position 20 is also excluded based on H 1 NMR (no signal appeared around d 2.0 for CH3-CO-). Based on the previous spectral data [7] and that of the following reactions, this degradated compound was considered to be 6/?-methyl-5a-pregnane-3/?,5,6a, 20a-tetrol-16-one (13). Oxidation of this product with Jone's reagent resulted in the formation of the diketone product (14) which on its treatment with alcoholic potassium hydroxide selectively eliminated the C-5 tertiary hydroxyl group and not the C-6 one to form product (15) .
Experimental
Melting points were determined using a Büch 510 apparatus. IR spectra were recorded using Beckmann spectrophotometer 4220. Mass spectral data were obtained with mass spectrophotometer MAT 112. NMR spectra were taken at 60 MHz with a Varian T-60 A instrument in CDCI3 using trimethyl silane as the internal standard. Ultraviolet spectra were recorded on CE 595 double beam digital Ultraviolet spectrophotometer.
5a-(25R)-Spirostane-3 ß ,5,6 ß-triol (2)
Diosgenin (1) (5 g, 0.012 mole) in THF (65 ml) and HCOOH (90%, 45 ml. 1.07 mole) were heated in a steam-bath for 15 min, then cooled to room temperature. H202 (30% v/v, 10 ml, 0.09 mole) was added, followed by shaking for 6 h, after which cold H20 (100 ml) was added, the formate ppt. formed was filtered, dissolved in MeOH 125 ml and KOH (50%,, 6.5 ml), refluxed for 30 min. cooled, acidified with AcOH and H202 (200 ml) was added. The formed product 2 was filtered (5.3 g, 98% yield) which was crystallized from MeOH to give colourless plates, m.p. 282-284 °C, undepressed by an authentic sample [8] .
Degradation of diosgenin (1) to 5 a-pregnane-3 ß,5,6 ß,16 ß,20 a-pentol (3)
Diosgenin (1), (5 g, 0.012 mole) in THF (65 ml) and HCOOH (90%, 90 ml, 2.14 mole) was heated on a steam-bath for 15 min, cooled, treated with H2OO (30%, v/v, 20 ml, 0.18 mole) and stirred for 48 b. Water as then added (100 ml), after the extraction with CHCI3 and evaporation, the formate of 3 was obtained, dissolved in MeOH (125 ml) and KOH (50%, 6.5 ml), and the solution was refluxed for 30 min. cooled. The substance was extracted with CHCI3 after acidification with AcOH and addition of H20. Evaporation of the CHCI3 extract gave one g of 3. The aqueous layer after concentration gave 3. 
6ß-Methyl-5a-(25R)-spirostane-3ß,5,6 a-triol (8)
Compound 7 (5 g, 0.01 mole) in THF (500 ml) was added to a solution of CH3MgI (Mg 0.3 g, 0.1 mole; CH3I, 20 g, 0.14 mole in ether 50 ml), refluxed for 3 h, decomposed after cooling with NH4CI solution, extracted with CHCI3 and processed to give 6-methyl spirostane product (8) 
6ß-Methyl-5 a-(25R)-spirostane-5,6a-diol-3-one
A solution at 0 c C of product 8 (0.5 g, 0.001 mole in dry Me2CO, 100 ml) was treated with Jone's [11] reagent (2 ml) and processed as usual to yield fine needles of product 9 in 80% yield (400 mg), m.p. 226-228 c C (acetone). Reported [10] m.p. 245 to 247 °C. IR v™ cm -1 : 3400 (OH), 1700 (-0=0). 920, 880. 860 and 820 (spirostane side-chain). MS. m/e: 460 (M+, C28H4405).
6ß-Methyl-(25R)-spirost-4-en-6a-ol-3-one
To product 9 (0.5 g, 0.001 mole) in MeOH (150 ml) was added KOH (15%, 7.5 ml) and refluxed for 2 h. The reaction mixture was then concentrated in vacuo (to 50 ml), H20 was added to give compound 10 in 90% yield (0.45 g); m.p. 228-232 °C (EtOH). Reported [5] m.p. 233-235 C. UV:
239 (e 15,600). IR v™ cnr 1 : 3480 (OH). 1670 (C=C-C=0), 1600 (>C=C<), 960. 920. 880 and 860 (spirostane sidechain).
6ß-Methyl-5 a-(25R)-spirostane-3 ß.5,6 a-triol-3-acetate (11)
Mild acetvlation of compound 8 (100 mg. 0.002 mole) in dry pyridine (1 ml)/Ac20 (0.5 ml) gave the acetate derivative (11 To a solution of product 8 (2 g, 0.048 mole), in THF (25 ml) was added HCOOH (90%, 216 ml, 5.16 mole) and heated on a steam-bath for 15 min, cooled at room temperature then H2O2 (30% v/v 24 ml, 0.23 mole) was added under stirring and left on water-bath for 48 h. The formate derivative was extracted with CHCI3 after the addition of H2O2, dissolved in MeOH (25 ml), treated with KOH (50%, 10 ml), refluxed for one h, cooled, acidified with AcOH and (100 ml) was added to give a colourless precipitate (A). The filterate was extracted with CHCI3 to give fraction (B). Fractions (A) and (B) were identical (1.5 g) and chromatographed on a column of silica gel (60 g, 2 x 150 cm). Elution with CHCI3 gave 100 mg of the starting material 8. The next fraction also eluted with CHCI3 Treatment of 6ß-methyl-5a-pregnane-3ß, 6 a,20a-tetrol-16-one (13) with alcoholic potassium hydroxide To compound 13 (5 mg) in MeOH (15 ml) was added aqueous KOH (15%; 0.8 ml) and refluxed for 6 h. Processing of the reaction gave the starting material 13 m.p. 270-273 °C (identical IR spectra).
6ß-Methyl-5a-pregnane-5,6a,20a-triol-3,16-dione
A solution of product 13 (0.5 g, 0.0013 mole) in dry Me2CO (100 ml) was cooled to 0 °C and treated with Jone's [11] reagent (2 ml).
It gave product 14 (400 mg, 80% yield), m.p. 
